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Abstract In ba¢lomycin A1-resistant cells (Vero-317 and MC-
3T3-E1), ba¢lomycin A1 neither inhibited cell growth, induced
cell death, nor activated caspase-3. However, 100 nM ba¢lomy-
cin A1 did raise the lysosomal pH similar to 10 mM NH4Cl.
Prodigiosins, H+/Cl3 symporters that raise the lysosomal pH,
inhibited cell growth through apoptosis and caused the activa-
tion of caspase-3. Concanamycin A also inhibited the growth of
these cells through apoptosis. 10 mM NH4Cl inhibited the
growth of these cells as well, but cytostatically. These results
suggest that plecomacrolides inhibited cell growth apoptotically
through speci¢c site(s), in contrast to the cytostatic e¡ect of 10
mM NH4Cl, besides raising the lysosomal pH.
. 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Plecomacrolides, including ba¢lomycins and concanamy-
cins, have been shown to inhibit vacuolar type Hþ-ATPase
(V-ATPase) more strongly than phosphorylated Hþ-ATPase
[1] and therefore are thought to be ‘speci¢c’ inhibitors of
V-ATPase [2,3]. However, their binding site is disputed: sub-
unit c (16 kDa), subunit a (116 kDa), or other subunit pro-
teins on V-ATPase [4^7]. Recent evidence using a photoa⁄n-
ity labeling derivative of a concanamycin analogue suggested
that plecomacrolides bind to subunit c [8]. The relationship of
plecomacrolides with destruxins or enamides [9^11] (both in-
hibitors of V-ATPases) is not completely clear yet. Ba¢lomy-
cin A1 not only inhibited cell growth [12,13], but also induced
cell di¡erentiation [14,15] and apoptosis [2,3,16] by unknown
mechanisms. Prodigiosins also inhibited the acidi¢cation of
intracellular vesicles, including lysosomes, with little inhibition
of ATP hydrolysis [17^20], and were found to act as Hþ/Cl3
symporters [21]. In fact, prodigiosins inhibited proton pumps
of respiration (Tanaka et al., in preparation) and Hþ-pyro-
phosphatase [22]. Recently, cycloprodigiosin, like plecomacro-
lides, was found to induce cell di¡erentiation and apoptosis in
HL-60 cells [23] ; the mechanism of its action remains to be
clari¢ed.
In the present paper, we report that (1) ba¢lomycin A1 did
not inhibit the growth of Vero-317 or MC-3T3-E1 cells, but
that (2) 100 nM ba¢lomycin A1, like 10 mM NH4Cl, raised
the lysosomal pH in each of these cell lines, and that (3)
prodigiosins and concanamycin A inhibited the cell growth
apoptotically. We also showed that (4) 10 mM NH4Cl inhib-
ited growth cytostatically.
2. Materials and methods
2.1. Materials
2P,7P-Bis(carboxyethyl)-5(6)-carboxy£uorescein-tetraacetoxymethyl
ester (BCECF-AM) was purchased from Molecular Probes (Eugene,
OR, USA). Hoechst 33258, propidium iodide (PI) and other chemicals
were purchased mostly from Sigma (St. Louis, MO, USA).
2.2. Cell culture
CHO-K1 cells (a Chinese hamster ovary cell line) were cultured in
F-12 Ham (Nissui, Tokyo, Japan) plus 10% fetal bovine serum (FBS;
Wako, Tokyo, Japan) and antibiotics (100 U/ml penicillin and 100 Wg/
ml streptomycin). PC12 cells (a rat pheochromocytoma cell line) were
cultured in Dulbecco’s modi¢ed essential medium (Eagle) (DMEM;
Nissui) plus 10% FBS (Wako), 5% horse serum (Wako) and antibi-
otics (see above). Vero-317 cells (a subclone of Vero cells from the
African green monkey kidney, RCB-0272; RIKEN Cell Bank, Wako,
Japan) were cultured in minimum essential medium (Eagle) (Nissui)
plus 10% FBS and antibiotics. MC-3T3-E1 cells (C57BL/6 mouse
¢broblast-like cells that can di¡erentiate into osteoblasts, RCB-
1126; RIKEN Cell Bank) were cultured in DMEM plus 10% FBS
and antibiotics.
2.3. Determination of cell growth
Cell growth was measured based on the £uorescence increase of
Hoechst 33258 due to the binding to DNA [12], according to [24].
2.4. Determination of caspase activity
Caspase-3 activity was measured using EnzChek0 Caspase-3 Assay
Kit #1 of Molecular Probes according to the manufacturer’s instruc-
tions. The £uorescence of 7-amino-4-methylcoumarin (AMC) released
0014-5793 / 03 / $22.00 M 2003 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
doi:10.1016/S0014-5793(03)00084-X
*Corresponding author. Fax: (81)-76-234 4462.
E-mail address: ohkuma@kenroku.kanazawa-u.ac.jp (S. Ohkuma).
Abbreviations: BCECF-AM, 2P,7P-bis(carboxyethyl)-5(6)-carboxy-£u-
orescein-tetraacetoxymethyl ester; DIDS, 4,4P-diisothiocyanatostil-
bene-2,2P-disulfonic acid; DMEM, Dulbecco’s modi¢ed essential me-
dium (Eagle); DMSO, dimethylsulfoxide; FBS, fetal bovine serum;
FD, £uorescein-labeled dextran; PBS(-), phosphate-bu¡ered saline
without Mg2þ and Ca2þ ; PI, propidium iodide; V-ATPase, vacuolar
type Hþ-ATPase
FEBS 26990 13-2-03 Cyaan Magenta Geel Zwart
FEBS 26990 FEBS Letters 537 (2003) 79^84
from Z-DEVD-AMC substrate (E-13183) was measured at Vex = 350
nm and Vem = 450 nm in a spectro£uorometer (F-4500; Hitachi).
2.5. Estimation of lysosomal pH (pHL) by £uorescein-labeled dextran
(FD) £uorescence
Cells were cultured with 10 mg/ml of FD (MWW70 000) overnight
and their £uorescence was observed under a confocal laser scanning
£uorescence microscope (LSM-510; Karl Zeiss, Nagoya, Japan) with
excitation at 488 nm (argon laser). The intensity of the light was kept
constant during the measurement.
2.6. Estimation of cytoplasmic pH (pHC)
Cultured cells (2U106) were treated with 0.05% trypsin^0.02%
EDTA, centrifuged (1000 rpm for 5 min) and suspended in 2 ml of
complete medium. The cells were incubated at 37‡C for 30 min in 10
WM BCECF-AM, washed twice with phosphate-bu¡ered saline with-
out Mg2þ and Ca2þ (PBS(3)) and suspended in complete medium.
Their £uorescence was measured in a spectro£uorometer (F-4500;
Hitachi) with Vex = 490 nm and Vem = 530 nm. The calibration of
pHC was done in situ using 1 WM nigericin-containing bu¡er that
mimics cytoplasm according to [25].
2.7. Estimation of viability and apoptosis
The £uorescence of non-¢xed cells was viewed under a £uorescence
microscope (Karl Zeiss) using 50 nM PI (G-excitation with ¢lter #20;
red £uorescence for nuclei of dead cells) and/or 10 Wg/ml of Hoechst
33258 (V-excitation with ¢lter #1; blue £uorescence for nuclei); nu-
clear condensation or fragmentation is observed in apoptotic cells
with either stain. FACS (£uorescence-activated cell sorter) using a
FACSCalibur HG 3 Color type (Becton-Dickinson, San Jose, CA,
USA) was also used to detect apoptosis (sub-G0/G1 cells) according
to the manufacturer’s instructions.
3. Results
3.1. Ba¢lomycin A1 resistance of Vero-317 and MC-3T3-E1
cells
We found that ba¢lomycin A1 did not inhibit the growth of
Vero-317 cells or MC-3T3-E1 cells [2,3], whereas it inhibited
the growth of CHO-K1 and PC12 cells [12] : IC50s were s 500
nM^1 WM against Vero-317 and MC-3T3-E1 cells, versus
5^10 nM against CHO-K1 and PC12 cells (Fig. 1). In fact,
in the ba¢lomycin A1-resistant (Vero-317 and MC-3T3-E1)
cells, 100 nM ba¢lomycin A1 did not increase the caspase-3
activity required for apoptosis : 0.8 V 0.2^1.0 V 0.0 and 1.0V 0^
1.0V 0 times that of the control level, respectively
(meanVS.D., n=3), after 24^48 h. In contrast, 100 nM ba¢-
lomycin A1 activated caspase-3 in PC12 and HeLa cells after
40 h: 3.6 V 0.1 and 4.2 V 0.2 times the control level, respec-
tively (meanVS.D., n=3), consistent with the data on conca-
namycin A [26].
3.2. pHL was increased by ba¢lomycin A1 in the ba¢lomycin
A1-resistant cells
The £uorescence intensity of FD increases as the pH in-
creases from 3 to 8 [27]. Fig. 2 shows views under a confocal
£uorescence microscope of FD-containing cells. PC12 cells are
sensitive to ba¢lomycin A1 while Vero-317 and MC-3T3-E1
cells are both resistant to ba¢lomycin A1. To our surprise, 100
nM ba¢lomycin A1, like 10 mM NH4Cl, increased the £uo-
rescence intensity of all cells after 30 min, indicating arise in
pHL. These results show that the pHL was increased by ba¢-
lomycin A1 even in the ba¢lomycin A1-resistant cells.
The pHC of both Vero-317 and MC-3T3-E1 cells was about
7.6, which was slightly higher than that of PC12 cells (7.2).
This is again contrary to expectation. The slightly higher pHC
decreased slightly, to 7.2, after treatment with either ba¢lo-
mycin A1, amiloride or 4,4P-diisothiocyanatostilbene-2,2P-di-
sulfonic acid (DIDS) (data not shown).
3.3. Inhibition of the growth of ba¢lomycin A1-resistant cells
through apoptosis by prodigiosins
It is possible that ba¢lomycin A1-resistant cells are defective
in apoptosis in general. Recently, cycloprodigiosin was found
to induce cell di¡erentiation and apoptosis in HL-60 cells [23]
similar to ba¢lomycin A1. As shown in Fig. 3, the growth of
MC-3T3-E1 cells was inhibited by prodigiosins. The growth
of Vero-317 cells was also inhibited by prodigiosins. The IC50s
of prodigiosin and metacycloprodigiosin against the growth of
Vero-317 and MC-3T3-E1 cells were both about 10 nM, in
contrast to values of 800 nM and 600 nM, respectively,
against the growth of PC12 cells. The apoptosis of these cells
by prodigiosins was evident from the nuclear condensation
and fragmentation (Fig. 4 for MC-3T3-E1 cells; Vero-317
cells showed similar results). FACS also indicated an increase
in sub-G0/G1 cells in both populations (data not shown). Pro-
digiosins, as well as cisplatin (15 Wg/ml for 40 h) [28], activated
the caspase-3 of these cells (2^3.5 times; data not shown).
3.4. Inhibition of the growth of ba¢lomycin A1-resistant cells
through apoptosis by concanamycin A
Do other plecomacrolides a¡ect the growth of ba¢lomycin
A1-resistant cells? As shown in Fig. 5, the growth of the
ba¢lomycin A1-resistant cells was inhibited by concanamycin
A. The IC50s of concanamycin A against the growth of Vero-
317 and MC-3T3-E1 cells were about 0.3 nM and 10 nM,
respectively. The IC50 of concanamycin A against the growth
of PC12 cells was about 10 nM. The apoptosis of these cells
by concanamycin A was evident from their nuclear condensa-
tion and fragmentation (as detected with Hoechst 33258 stain-
ing) as well as the increase of sub-G0/G1 cells in FACS anal-
yses (data not shown).
Fig. 1. E¡ect of ba¢lomycin A1 on the growth of CHO-K1 (E),
PC12 (a), Vero-317 (F) and MC-3T3-E1 (b) cells. Cell growth was
estimated by the determination of cellular DNA content using
Hoechst 33258 and a spectro£uorometer (Hitachi model F-4500,
Vex = 356 nm and Vem = 458 nm). Data represent the meanVS.D.
(n=4).
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3.5. Cytostatic inhibition of the growth of cells by 10 mM
NH4Cl
At 10 mM, NH4Cl increased the pHL of the ba¢lomycin
A1-resistant Vero-317 and MC-3T3-E1 cells as well as the
ba¢lomycin A1-sensitive CHO-K1 and PC12 cells (Fig. 2).
At the same time, NH4Cl inhibited the growth of all of these
cells, with almost the same IC50 (V2 mM) (Fig. 6). However,
all of these cells were viable in the presence of 10 mM NH4Cl
according to the viability test using PI (Fig. 7). This is in
contrast to the apoptotic death of PC12 cells caused by ba¢-
lomycin A1, as detected with PI and Hoechst 33258 (Fig. 7).
However, arrest at a speci¢c stage of the cell cycle was not
evident at 10 mM NH4Cl. PC12 cells were dead after treat-
ment with 100 mM NH4Cl (or 25 WM chloroquine), but they
were not apoptotic, in contrast to cells treated with 100 WM
ba¢lomycin A1 (Fig. 7).
4. Discussion
The mechanism of growth inhibition by ba¢lomycin A1 is
not known [2,3,12,13]. The results in this paper indicate that
ba¢lomycin A1 increased the pHL even in the ba¢lomycin A1-
resistant Vero-317 and MC-3T3-E1 cells. These cells still show
growth inhibition through apoptosis in response to prodigio-
sins or cisplatin. This indicates that the sole increase in pHL is
actually a minor factor in growth inhibition induced by ba¢-
lomycin treatment. This is in accordance with previous ¢nd-
ings that ba¢lomycin A1-induced apoptosis of PC12 cells oc-
curs independently of intracellular pH [15]. This also suggests
that ba¢lomycin A1 had no e¡ect on the growth of Vero-317
or MC-3T3-E1 cells probably because it did not produce ap-
optosis in these cells even though it raised their pHL.
Recently, the participation of caspase(s) has been suggested
in ba¢lomycin A1-induced apoptosis, consistent with the ¢nd-
ing with concanamycin A [26]. Concanamycin A induced
growth inhibition and apoptosis of Vero-317 and MC-3T3-
E1 cells, suggesting that it induced apoptosis through speci¢c
apoptosis receptor site(s) di¡erent from ba¢lomycin A1. Re-
cently, evidence was presented suggesting that the site in
V-ATPase for the binding of concanamycin in Neurospora
Fig. 2. E¡ects of ba¢lomycin A1 on the pHL of MC-3T3-E1 cells. Cells were cultured in 10 mg/ml FD-containing medium overnight (about 18
h) before being washed twice with PBS(3) and cultured in a drug-containing medium at 37‡C for 30 min. The bars represent 50 Wm. A^C:
PC12 cells. D^F: Vero 317 cells. G^I: MC-3T3-E1 cells. A,D,G: 1% dimethylsulfoxide (DMSO). B,E,H: 10 mM NH4Cl. C,F,I: 100 nM ba¢lo-
mycin A1.
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crassa is di¡erent from that for binding of ba¢lomycin A1 [7].
Concanamycin A induced caspase-3-dependent cleavage of
retinoblastoma protein, poly(ADP-ribose) polymerization
[26] and intracellular apoptotic factor (33 kDa) in B-cell hy-
bridoma HS-72 [29]. It also induced release of cytochrome c
and decreased heat shock protein of 27 kDa in a human sub-
mandibular gland ductal cancer cell line (HGS) [30]. It would
be interesting to see if ba¢lomycin A1 and other V-ATPase
inhibitors (including prodigiosins) induce similar e¡ects.
The mechanism of induction of apoptosis by prodigiosins is
not clear yet. It might be similar to that of plecomacrolides
because both types of compounds have similar e¡ects on cells
(cell di¡erentiation and apoptosis). On the other hand, ba¢-
lomycin A1 selectively inhibits the ATP hydrolysis of V-ATP-
ase, while prodigiosins act as Hþ/Cl3 symporters and inhibit
proton translocation non-speci¢cally with little e¡ect on sub-
strate catalysis (ATP/inorganic phosphate hydrolysis or respi-
ration). The decrease in pHC has been implicated in the apo-
ptosis of liver cancer cell lines, HL-60 cells and breast cancer
by cycloprodigiosin because 10 mM imidazole concomitantly
Fig. 3. E¡ects of prodigiosins on the growth of MC-3T3-E1 cells.
The growth of MC-3T3-E1 was estimated as in Fig. 1. Data repre-
sent the meanVS.D. (n=4). F, metacycloprodigiosin; b, prodigio-
sin.
Fig. 4. Metacycloprodigiosin caused apoptosis in MC-3T3-E1 cells.
The £uorescence of non-¢xed cells was viewed after staining with
Hoechst 33258 at 37‡C for 30 min. The bars represent 50 Wm. A^C:
PC12 cells. D^F: MC-3T3-E1 cells. A,D: 1% DMSO. B,E: 100 nM
ba¢lomycin A1. C,F: 2 WM metacycloprodigiosin.
Fig. 5. E¡ects of concanamycin A on the growth of Vero-317 (F)
and MC-3T3-E1 (b) cells. Cell growth was estimated as in Fig. 1.
Data represent the meanVS.D. (n=4).
Fig. 6. E¡ects of NH4Cl on the growth of CHO-K1 (E), PC12 (a),
Vero-317 (F) and MC-3T3-E1 (b) cells. Cell growth was estimated
as in Fig. 1. Data represent the meanVS.D. (n=4).
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inhibited apoptosis and the decrease in pHC [23,31,32]. In
PC12 cells, however, 10 mM NH4Cl or imidazole inhibited
neither the neurite outgrowth nor the apoptosis caused by
prodigiosins (manuscript in preparation). Furthermore, there
is a paper insisting that the copper-promoted nuclease activity
of prodigiosins correlated well with their death-inducing e¡ect
[33].
In ba¢lomycin A1-resistant cells, the pHC (7.6) was slightly
higher than that in the PC12 cells (7.2). The reason for the
more alkaline pHC in the ba¢lomycin A1-resistant cells is not
clear at the moment. The higher pHC was reduced only
slightly to 7.2 by either ba¢lomycin A1, amiloride or DIDS,
suggesting little participation of V-ATPase, Naþ/Hþ antiport-
ers or Cl3/HCO33 antiporters [34,35]. Also, concanamycin A
had only a minor e¡ect on the pHC in the ba¢lomycin A1-
resistant cells. In fact, functional V-ATPase was hardly detect-
able on the plasma membranes of Vero-317 or MC-3T3-E1
cells, as judged by the recovery from acidic pHC caused by
rapid removal of NH4Cl from the medium [36] (data not
shown).
In acidic vesicles, the pH clearly a¡ects cellular functions,
but the functional role(s) of vacuolation (swelling of acidic
vesicles) is not clear [37]. This is the reason why researchers
prefer ba¢lomycin A1 to NH4Cl: ba¢lomycin A1 only raises
the pH, while NH4Cl both raises the pH and causes vacuola-
tion, in acidic vesicles. Furthermore, ba¢lomycin A1 has been
thought to inhibit cell growth by increasing the pH (main-
tained by V-ATPase) in acidic vesicles [12,13]. However, the
present results suggest that the sole increase in pH of acidic
vesicles did not inhibit cell growth. Furthermore, we found
that 10 mM NH4Cl inhibited cell growth cytostatically, while
100 WM ba¢lomycin A1 inhibited it apoptotically. The paper
examining the e¡ect of basic substances on the growth of 3T3
¢broblasts [37] and the one examining the parallel increase of
pHL between NH4Cl- and ba¢lomycin A1-treated cells [12]
contain signi¢cant divergences. The mechanism of growth in-
hibition by 10 mM NH4Cl, as well by ba¢lomycin A1, is still
to be clari¢ed.
It must be emphasized that it was impossible to see the
combined e¡ect of alkalinization and vacuolation in acidic
vesicles, before the discovery of ba¢lomycin A1-resistant cells.
Furthermore, the properties and relationships of the site(s) of
various inhibitors against V-ATPase (including prodigiosins)
for di¡erentiation and for death remain to be clari¢ed. Studies
on their clari¢cation are now in progress in our laboratory.
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